Avalo Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Avalo Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
Avalo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.85M, a 93.9% increase year-over-year.
Avalo Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.72M, a 5.05% increase year-over-year.
Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.48M, a 54% decline from 2022.
Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.55M, a 7.56% decline from 2021.
Avalo Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.17M, a 20.4% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$3.48M	-$4.08M	-54%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-29
2022	$7.55M	-$618K	-7.56%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-29
2021	$8.17M	+$1.39M	+20.4%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-29
2020	$6.79M	+$4.32M	+176%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-02
2019	$2.46M	+$31.7K	+1.31%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-08
2018	$2.43M	+$1.27M	+110%	Jan 1, 2018	Dec 31, 2018	10-K	2020-03-11
2017	$1.16M	-$538K	-31.7%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-18
2016	$1.69M	+$1.3M	+329%	Jan 1, 2016	Dec 31, 2016	10-K	2018-04-02
2015	$395K	-$692K	-63.7%	Jan 1, 2015	Dec 31, 2015	10-K	2018-04-02
2014	$1.09M			Jan 1, 2014	Dec 31, 2014	10-K	2016-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.